All terms in MESH
| Label | Id | Description |
|---|---|---|
| PS-6 | C025707 | |
| Thymopentin | D016305 | [Synthetic pentapeptide corresponding to the amino acids 32-36 of thymopoietin and exhibiting the full biological activity of the natural hormone. It is an immunomodulator which has been studied for possible use in the treatment of rheumatoid arthritis, AIDS, and other primary immunodeficiencies.] |
| Thymopoietins | D013946 | [Two closely related polypeptides (molecular weight 7,000) isolated from the thymus gland. These hormones induce the differentiation of prothymocytes to thymocytes within the thymus. They also cause a delayed impairment of neuromuscular transmission in vivo and are therefore believed to be the agent responsible for myasthenia gravis.] |
| Vena Cava Filters | D016306 | [Mechanical devices inserted in the inferior vena cava that prevent the migration of blood clots from deep venous thrombosis of the leg.] |
| Embolic Protection Devices | D057505 | [Vascular filters or occlusive devices that provide mechanical protection of the distal end organ from blood clots or EMBOLISM-causing debri dislodged during ENDOVASCULAR PROCEDURES.] |
| Enkephalin, Leucine-2-Alanine | D016308 | [A delta-selective opioid (ANALGESICS, OPIOID). It can cause transient depression of mean arterial blood pressure and heart rate.] |
| Enkephalin, Leucine | D004743 | [One of the endogenous pentapeptides with morphine-like activity. It differs from MET-ENKEPHALIN in the LEUCINE at position 5. Its first four amino acid sequence is identical to the tetrapeptide sequence at the N-terminal of BETA-ENDORPHIN.] |
| quinethazone | C050700 | |
| nitroacetic acid methyl ester | C025733 | |
| atipamezole | C050701 | |
| chorionic alpha(1)-microglobulin | C025734 | |
| substance P, Arg(1)-Pro(2)-Trp(7,9)-Leu(11)- | C050702 | |
| Aeron | C025735 | |
| sn-glycerol-3-phosphorylcholine synthetase | C050703 | |
| Outliers, DRG | D016311 | [In health care reimbursement, especially in the prospective payment system, those patients who require an unusually long hospital stay or whose stay generates unusually high costs.] |
| Diagnosis-Related Groups | D003953 | [A system for classifying patient care by relating common characteristics such as diagnosis, treatment, and age to an expected consumption of hospital resources and length of stay. Its purpose is to provide a framework for specifying case mix and to reduce hospital costs and reimbursements and it forms the cornerstone of the prospective payment system.] |
| Trasidrex | C025736 | |
| achatinin(H) | C050704 | |
| Treatment Refusal | D016312 | [Termination of hospitalization by PATIENTS against advice of healthcare provider and unknown to the provider or institution., Patient or client refusal of or resistance to medical, psychological, or psychiatric treatment. (APA, Thesaurus of Psychological Index Terms, 8th ed.), Patient or surrogate refusal of specific type of anesthesia or any anesthesia.] |
| Patient Rights | D028701 | [In law, the claim of persons involuntarily institutionalized on the ground of mental disability to receive appropriate care for their conditions or diseases. (Bioethics Thesaurus), Fundamental claims of patients, as expressed in statutes, declarations, or generally accepted moral principles. (Bioethics Thesaurus) The term is used for discussions of patient rights as a group of many rights, as in a hospital's posting of a list of patient rights.] |